Epigenetic changes in diabetes
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes is a multifactorial disease with numerous pathways influencing its progression and recent observations suggest that the complexity of the disease cannot be entirely accounted for by genetic predisposition. A compelling argument for an epigenetic component is rapidly emerging. Epigenetic processes at the chromatin template significantly sensitize transcriptional and phenotypic outcomes to environmental signaling information including metabolic state, nutritional requirements and history. Epigenetic mechanisms impact gene expression that could predispose individuals to the diabetic phenotype during intrauterine and early postnatal development, as well as throughout adult life. Furthermore, epigenetic changes could account for the accelerated rates of chronic and persistent microvascular and macrovascular complications associated with diabetes. Epidemiological and experimental animal studies identified poor glycemic control as a major contributor to the development of diabetic complications and highlight the requirement for early intervention. Early exposure to hyperglycemia can drive the development of complications that manifest late in the progression of the disease and persist despite improved glycemic control, indicating a memory of the metabolic insult. Understanding the molecular events that underlie these transcriptional changes will significantly contribute to novel therapeutic interventions to prevent, reverse or retard the deleterious effects of the diabetic milieu.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“In accordance with the metabolic memory hypothesis, lower incidence of macrovascular complications in the intensive therapy group was observed when compared to the conventional treatment group 10 years post-trial (40).”
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012 · cited 1×
“Largely unstructured N-terminal tails extending from each histone protein harbor amino acid residues that are substrates for a variety of post-translational enzymatic modifications (3, 51).”
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Epigenetic Reprogramming in Mammalian Development
Reik, W., Dean, W., & Walter, J. (2001) · Science · doi:10.1126/science.1063443 · Cited by 3,078 · cited 1×
“Regulatory regions of mammalian genes are subject to dynamic methyl modifications during development (93).”
A pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 1×
“Several genes that participate in crucial pathways that are deregulated in diabetes are regulated by miRs (129, 130), most significantly TGF-β signaling in diabetic nephropathy (131, 132).”
Bernstein, B. E., Meissner, A., & Lander, E. S. (2007) · Cell · doi:10.1016/j.cell.2007.01.033 · Cited by 2,086 · cited 2×
“Integration of epigenetically recorded information to this dynamically interactive system greatly influences gene expression and cellular phenotype (5).”
Epigenetics and the environment: emerging patterns and implications
Feil, R., & Fraga, M. F. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3142 · Cited by 1,929 · cited 1×
“Epigenetic processes at the chromatin template significantly sensitize transcriptional and phenotypic outcomes to signaling information associated with metabolic state, requirements, history, and extracellular interactions, which can be assimilated into this coordinated system (10).”
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115 · cited 4×
“With regard to inflammation associated with diabetic vascular disease, aortic endothelial cells from mice subjected to a hyperglycemic clamp for 3 h displayed significantly increased expression of the pro-inflammatory NFκB p65 subunit (encoded by RELA) that persisted for up to 6 days beyond normalization of blood gluc…”
InfluentialSelf-citationZhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815 · cited 1×
“Recent investigations revealed that subjects who received continuous intensive treatment throughout both trials were at significantly lower risk of macrovascular complications including atherosclerosis (36, 37), cardiovascular disease and stroke (38).”
Parental transmission of type 2 diabetes: the Framingham Offspring Study
Meigs, J. B., Cupples, L. A., & Wilson, P. W. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2201 · Cited by 666
Park, J. H., Stoffers, D. A., Nicholls, R. D., & Simmons, R. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33655 · Cited by 640 · cited 2×
“A study conducted on a rat model of intrauterine growth retardation (IUGR) revealed that among other epigenetic processes, expression of pancreatic and duodenal homeobox 1 (PDX1 ) is silenced by DNA-methylation-driven transcriptional repression during transition from IUGR to diabetes in adults (96).”
Non-CpG methylation of the PGC-1α promoter through DNMT3B controls mitochondrial density.
Barrès, R., Osler, M. E., Yan, J., Rune, A., Fritz, T., Caidahl, K., Krook, A., & Zierath, J. R. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.07.011 · Cited by 602 · cited 1×
“Genomewide promoter methylation analysis of skeletal muscle from patients with T2DM revealed similar observations (112).”
Iguchi-Ariga, S. M., & Schaffner, W. (1989) · Genes & Development · doi:10.1101/gad.3.5.612 · Cited by 559 · cited 1×
“DNA methylation is strongly associated with stable silencing of regulatory and coding regions by specific recruitment of chromatin remodeling complexes to establish transcriptionally repressive chromatin (87–89) and by preclusion of transcription factor binding (90).”
Excessive Obesity in Offspring of Pima Indian Women with Diabetes during Pregnancy
Pettitt, D. J., Baird, H. R., Aleck, K. A., Bennett, P. H., & Knowler, W. C. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302033080502 · Cited by 530 · cited 1×
“This is exemplified by follow-up studies of Pima Native Americans that demonstrate significantly higher predisposition to T2DM for individuals born to diabetic mothers than offspring of nondiabetics and importantly siblings born prior to maternal T2DM diagnosis (20, 21).”
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
Ling, C., Del Guerra, S., Lupi, R., Rönn, T., Granhall, C., Luthman, H., Masiello, P., Marchetti, P., Groop, L., & Del Prato, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0916-5 · Cited by 495 · cited 1×
“Compared to healthy control subjects, DNA hypermethylation at the peroxisome proliferator-activated receptor-γ coactivator 1α (PPARGC1A) promoter and concomitant transcriptional repression was observed in pancreatic islets isolated from patients with T2DM (111).”
Progression of Incipient Diabetic Retinopathy During Good Glycemic Control
Engerman, R. L., & Kern, T. S. (1987) · Diabetes · doi:10.2337/diab.36.7.808 · Cited by 490 · cited 1×
“5 years before insulin therapy still developed retinopathy after 5 years of diabetes (29).”
Overexpression of Fibronectin Induced by Diabetes or High Glucose: Phenomenon With a Memory
Roy, S., Sala, R., Cagliero, E., & Lorenzi, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.404 · Cited by 409 · cited 1×
“Similar transient glucose exposure significantly increased expression of fibronectin and collagen IV that persisted in human endothelial cells despite reinstitution of normoglycemia (33).”
Li, Y., He, Y., Qi, L., Jaddoe, V. W., Feskens, E. J. M., Yang, X., Ma, G., & Hu, F. B. (2010) · Diabetes · doi:10.2337/db10-0385 · Cited by 384
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Yang, J., Huang, J., Dasgupta, M., Sears, N., Miyagi, M., Wang, B., Chance, M. R., Chen, X., Du, Y., Wang, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016147107 · Cited by 340 · cited 1×
“For instance Set7mediated methylation and subsequent modulation of STAT3 transactivity in response to IL-6 stimulation (82) could play a role in the development and progression of diabetic nephropathy (83, 84).”
Ek, J., Andersen, G., Urhammer, S. A., Gæde, P. H., Drivsholm, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2001) · Diabetologia · doi:10.1007/s001250100032 · Cited by 293 · cited 1×
“Expression of this gene is linked with islet insulin secretion and a recently described polymorphism in the coding region is associated with increased risk for T2DM (113).”
Epigenetic phenomena linked to diabetic complications
Pirola, L., Balcerczyk, A., Okabe, J., & El-Osta, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.188 · Cited by 239 · cited 1×
“Prolonged exposure to poor glycemic control leads to a host of diabetes-specific pathologies across multiple organ systems including microvascular complications of peripheral nerves, renal glomeruli and the retina (22).”
Self-citationKowluru, R. A., Kowluru, V., Xiong, Y., & Ho, Y.-S. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.012 · Cited by 233 · cited 1×
“To this end, overexpression of antioxidant enzymes in transgenic diabetic mice ameliorates the development of retinopathy (26), cardiomyopathy (27) and nephropathy (28).”
The genetic and epigenetic basis of type 2 diabetes and obesity
Drong, A. W., Lindgren, C. M., & McCarthy, M. I. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.149 · Cited by 212 · cited 1×
“Despite strong familial clustering of T2DM (16, 17) and identification of several common variants, genome-wide association studies provide limited capacity to predict T2DM (18).”
Distinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells
Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M. C., Cooper, M. E., & El-Osta, A. (2012) · Circulation Research · doi:10.1161/circresaha.112.266171 · Cited by 180
Self-citation
Cited by
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Diabetes: a 21st century challenge
Zimmet, P. Z., Magliano, D. J., Herman, W. H., & Shaw, J. E. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70112-8 · Cited by 1,062
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Martín-Timón, I. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 976
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., & Xu, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1161521 · Cited by 799
“Environmental factors and hyperglycemia contribute to epigenetic changes in DNA and histones, modulating gene expression in organs implicated in the pathogenesis and progression of T2DM and b-cell function (24).”
BackgroundKeating, S. T., & El-Osta, A. (2015) · Circulation Research · doi:10.1161/circresaha.116.303936 · Cited by 317
Self-citation
Metadata
- Authors
- Keating, S., & El‐Osta, A.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2013-03-11
- Volume
- 84
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W1945638502
- Cited by
- 86
- References
- 26
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.